首页 | 本学科首页   官方微博 | 高级检索  
     

长春瑞滨联合顺铂治疗晚期非小细胞肺癌38例疗效观察
引用本文:赵宏亮. 长春瑞滨联合顺铂治疗晚期非小细胞肺癌38例疗效观察[J]. 河南肿瘤学杂志, 2005, 18(6): 409-410
作者姓名:赵宏亮
作者单位:许昌市中心医院肿瘤科,河南许昌461000
摘    要:目的观察NP方案治疗晚期非小细胞肺癌的疗效与毒性。方法应用长春瑞滨25mg/m^2静脉点滴,第1,8天,DDP80~100mg/m^2静脉点滴,第1,2天。结果38例无CR,PR16例,NC16例,PD6例,总有效率42.1%。结论长春瑞滨联合顺铂治疗晚期NSCLC有效率高,毒副反应能耐受。

关 键 词:长春瑞滨 顺铂 非小细胞肺癌 化疗
文章编号:1003-1464(2005)06-0409-02
收稿时间:2005-03-08

Therapy Observation of Vinorelbine Combined with Cisplation in the Treatment of Advanced Non-Small Cell Lung Cancer
Zhao Hongliang. Therapy Observation of Vinorelbine Combined with Cisplation in the Treatment of Advanced Non-Small Cell Lung Cancer[J]. Henan Journal of Oncology, 2005, 18(6): 409-410
Authors:Zhao Hongliang
Affiliation:Department of Oncology, the Hospital of Xuchang, Xuchang 461000, China
Abstract:Objective To investigate the effect and toxicity of treatment of non-small cell lung cancer with NVB and DDP. Methods NVB 25 mg/m^2 in the 1st day and 8th day, and DDP 80 - 100 mg/m^2 in two days were given. Results There were 0 CR, 16 PR, 16 NC and 6 PD in the 38 patients. The response rate was 42.1%. Conclusion Treatment of non-small cell lung cancer with NVB and DDP was efficient and the toxicity was able to be tolerable.
Keywords:NVB    DDP   non-smaU cell lung cancer    chemotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号